Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study of Natural Killer T Cell Infusion in Patients With Advanced Solid Tumor

NCT02562963 is registered in ClinicalTrials.gov with Minghui Zhang as lead sponsor.

NCT NCT02562963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02562963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study of Natural Killer T Cell Infusion in Patients With Advanced Solid Tumor
Lead sponsor
Minghui Zhang
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 30, 2015
Completion date
December 31, 2024
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, gastric cancer, hepatocellular carcinoma, non-small cell lung cancer